Latest Valuation News

The Takeovers Panel has declined to conduct proceedings regarding Elanor Funds Management's concerns over disclosure in the LDR Assets takeover bid, as parties move to amend the bidder's statement.

TechGen Metals has raised A$1.2 million through a strongly supported placement to accelerate exploration at its Blue Devil and Mt Boggola projects, setting the stage for drilling campaigns in late 2025.

Pengana International Equities Limited has announced an on-market buy-back of up to 25.7 million ordinary shares, signaling a strategic capital management move without requiring shareholder approval.

Aurum Resources has reported impressive high-grade gold intercepts at its Napié Gold Project in Côte d’Ivoire, extending mineralisation depth and reinforcing its growth ambitions. The company is advancing a large-scale drilling campaign and plans key resource updates and a Pre-Feasibility Study by year-end.

US Masters Residential Property Fund reported robust first-half sales and significant debt reduction, while navigating a modest portfolio valuation dip primarily in New York.

Mount Gibson Iron has extended its on-market share buy-back program for another year, allowing up to 10% of issued shares to be repurchased. Since inception, the company has bought back 3.2% of its shares, signaling ongoing capital management efforts.

NSX Limited shareholders will decide on a recommended acquisition scheme offering $0.04 cash per fully paid share, representing a substantial premium. The Board and an independent expert endorse the deal, which would see NSX delisted and become a CNSX subsidiary.

Following the $75 million sale of its Robe Mesa Iron Ore Project, CZR Resources announces the vesting of nearly 5 million options and performance rights, opening the door to potential share conversions.

Computershare Limited has announced an ordinary dividend of AUD 0.48 per share for the half-year ending June 2025, alongside a confirmed Dividend Reinvestment Plan price of AUD 37.64.

Trading in Jindalee Lithium Limited shares has resumed following the company’s announcement of a potential merger, signaling a pivotal moment for the lithium miner.

Jindalee Lithium has signed a non-binding LOI to merge its US lithium assets with a US SPAC, aiming to list on a national exchange and unlock significant funding for its McDermitt Project.

Telix Pharmaceuticals has secured FDA agreement on a resubmission plan for its glioma imaging agent TLX101-CDx, aiming for a Q4 2025 filing that includes additional efficacy data. The FDA signals likely expedited review, underscoring the unmet medical need.